Web Based Investigation of Natural History of Keloid Disorder, an Online Survey

This trial intends to gather very basic clinical information about keloid, its patterns of presentation, family history, ethnic background and correlation with the type of keloid, as well as prior treatment results that patients have had received.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Keloid Cicatrix Cicatrix, Hypertrophic Collagen Diseases Connective Tissue Diseases Fibrosis Pathologic Processes Pathological Conditions, Signs and Symptoms Skin and Connective Tissue Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Michael H. Tirgan, MD

New York, 10023, United States

Location status: Recruiting

Location contact

Michael H Tirgan, MD

CONTACT

[email protected]

212-874-4200

Michael H Tirgan, MD

PRINCIPAL_INVESTIGATOR

About this study

This will be a web based study, whereby patients will have to read and acknowledge the consent form online. Once patients agree and acknowledge the terms of the consent form, they will gain access to the questionnaire pages.

For those who are under age of 18, a parent or a legal guardian must sign the consent form and answer the online questions on behalf of the patient.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients must have clinically confirmed diagnosis of keloid
Adults, age over 18
Parent or legal guardian may participate if patient is under the age of 18
Able and willing to complete a web based survey

Exclusion criteria

No one will be excluded from this study as long as the inclusion criteria are met.

Treatment and study plan

Primary outcomes

Determine the prevalence different phenotypes of keloid in participants.

Time frame: Two years

Prevalence of different phenotypes of keloid will be measured in the study population and reported. Prevalence of familial keloid in the study population will also be determined and reported. Data will be analyzed to determine the distribution of keloid among different ethic groups. Data will be analyzed to report the percentage of patients who have had one or more treatments and the percentage of patients who have had successful treatments.

Study contacts

Contact information is provided by the study sponsor or research team.

Michael H Tirgan, MD

CONTACT

[email protected]

(212) 874 4200

Sponsors and collaborators

Lead sponsor

Tirgan, Michael H., M.D.

Indiv

Registry information

Important dates

Study start: 2011
Primary completion: 2030
Study completion: 2031
First posted: Aug 26, 2011
Registry last updated: Oct 4, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Enrolling by Invitation